FDA Inspection 1018976 — Michael Schmitt, M.D.
The FDA completed an inspection of Michael Schmitt, M.D. on June 23, 2017 in Heidelberg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 23, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Heidelberg (Germany)
Additional Details
Clinical Investigator (CI)